Journal
NEUROBIOLOGY OF AGING
Volume 56, Issue -, Pages 202-210Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2017.03.001
Keywords
Alzheimer disease; Deep brain stimulation; Fornix; Memory; Ethics; Clinical trials
Categories
Funding
- Tasmania Graduate Research Scholarship - University of Tasmania
- Australian Research Council Discovery Early Career Researcher Award [DE150101390]
- Australian Research Council Centre of Excellence Scheme [CE 140100012]
- Australian Research Council [DE150101390] Funding Source: Australian Research Council
Ask authors/readers for more resources
The serendipitous discovery of triggered autobiographical memories and eventual memory improvement in an obese patient who received fornix deep brain stimulation in 2008 paved the way for several phase I and phase II clinical trials focused on the safety and efficacy of this potential intervention for people with Alzheimer's disease. In this article, we summarize clinical trials and case reports on fornix deep brain stimulation for Alzheimer's disease and review experiments on animal models evaluating the physiological or behavioral effects of this intervention. Based on information from these reports and studies, we identify potential translational challenges of this approach and determine practical and ethical considerations for clinical trials, focusing on issues regarding selection criteria, trial design, and outcome evaluation. Based on initial results suggesting greater benefit for those with milder disease stage, we find it essential that participant expectations are carefully managed to avoid treatment disenchantment and/or frustration from participants and caregivers. Finally, we urge for collaboration between centers to establish proper clinical standards and to promote better trial results comparison. (C) 2017 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available